Skip to content

Stroke and CPAP Outcome Study 2

Maximizing Use of Continuous Positive Airway Pressure in Stroke Rehabilitation Patients With Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02809430
Acronym
SCOUTS2
Enrollment
90
Registered
2016-06-22
Start date
2016-06-30
Completion date
2018-07-31
Last updated
2020-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Adherence, Sleep Apnea, Obstructive, Stroke

Brief summary

Obstructive sleep apnea (OSA) is associated with impaired stroke recovery. Treatment with continuous positive airway pressure (CPAP) may prevent this but is limited by poor adherence. In this study, the investigators enrolled eligible stroke patients undergoing inpatient rehabilitation (IPR) into an intensive CPAP adherence protocol (iCAP) with an aim to increase tolerance and adherence to auto-titrating CPAP (APAP).

Detailed description

The SCOUTS (Stroke and CPAP Outcome Study 2) was a single-arm, open-label study performed at 2 IPR units of the University of Washington. Eligible stroke patients undergoing IPR were provided an intensive CPAP adherence protocol (iCAP) to increase tolerance and adherence to auto-titrating CPAP (APAP). The iCAP included patient education and encouragement, device adjustments, close monitoring of adherence and a 3-night run-in period of APAP to identify those patients who 1. have OSA and 2. have APAP tolerance-- defined as participant willingness to continue APAP during IPR and over the 3-month treatment period. If both criteria were met, APAP treatment with iCAP continued during the rehabilitation stay and over a 3-month period. The goal of the intervention was to achieve 50% of subjects meeting APAP adherence (an average ≥ 4 hours per night) over the 3-month treatment period. The investigators evaluated if demographic, co-morbid or stroke-specific factors predicted APAP adherence and assessed the relationship between APAP adherence and neurological recovery from stroke.

Interventions

DEVICEContinuous Positive Airway Pressure

Auto-titrating Continuous Positive Airway Pressure (APAP) among patients admitted to a rehabilitation unit after ischemic or hemorrhagic stroke for 3 month treatment period.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients admitted after acute ischemic or hemorrhagic stroke to one of two inpatient rehabilitation units

Exclusion criteria

* The investigators will exclude participants if: their stroke was a subarachnoid hemorrhage or due to a secondary cause (vascular malformation, vasculitis, brain tumor, head trauma, or predisposition to bleeding); they have active CPAP use, advanced chronic lung disease requiring supplemental oxygen, heart failure (NYHA class III or IV); or they needed a nasogastric feeding tube.

Design outcomes

Primary

MeasureTime frameDescription
3-month CPAP Adherence3 monthsNumber of participants who continue CPAP after the run-in period who have acceptable adherence at 3 months, defined as using CPAP for an average of at least 4 hours a night on at least 70% of nights.

Secondary

MeasureTime frameDescription
CPAP ToleranceUpon discharge from rehabilitation unit, typically at 14-21 days from CPAP initiationNumber of eligible participants (those who continue CPAP after the run-in period) who are willing to continue CPAP treatment upon discharge from the rehabilitation unit.
Change in the Cognitive Functional Independence Measure (FIM) SubscoreBetween admission to rehabilitation unit and between 3-4 months following enrollmentChange in the cognitive subscale of the Functional Independence Measure (FIM) over 3 months. The FIM, a disability scale measuring the burden of care associated with aspects of motor and cognitive function, includes a motor and cognitive component. The cognitive subscale includes 5 cognitive items: comprehension, expression, social interaction, problem solving and memory. Each of the 5 cognitive items are scored from 1 (complete dependence) to 7 (complete independence). The total scores from these 5 items for the cognitive subscale range from 5 to 35 with lower scores indicating greater functional disability. The 5 items from the cognitive subscale are combined with 13 items from the motor subscale yielding the 18 items of the total FIM with a minimum score of 18 and a maximum score of 126 with lower scores indicating greater functional disability.
Change in the Motor Functional Independence Measure (FIM) SubscoreBetween admission to rehabilitation unit and between 3-4 months following enrollmentChange in the motor subscale of the Functional Independence Measure (FIM) over 3 months. The FIM, a disability scale measuring the burden of care associated with aspects of motor and cognitive function, includes a motor and cognitive component. The motor subscale includes 13 motor items: eating, grooming, bathing, upper body dressing, lower body dressing, toileting, bladder management, bowel management, bed/chair transfer, toilet transfer, tub/shower transfer, walk/wheelchair locomotion and stair locomotion. Each of the 13 motor items are scored from 1 (complete dependence) to 7 (complete independence). The total scores from these 13 items for the motor subscale range from 13 to 91 with lower scores indicating greater functional disability. The 13 items from the motor subscale are combined with 5 items from the cognitive subscale yielding the 18 items of the total FIM with a minimum total score of 18 and a maximum score of 126 with lower scores indicating greater functional
Change in NIH Stroke ScaleNIHSS scores were obtained in-person on enrollment and at 90 ± 7 days from enrollment.The National Institutes of Health Stroke scale (NIHSS) is a 15-item scale used to rank the severity of ischemic stroke. The NIHSS includes measurements for levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. The scores range from 0 to 42 with higher scores indicating greater neurologic impairment.

Countries

United States

Participant flow

Pre-assignment details

Over the 3-night run-in period with CPAP, 28 of the 90 patients enrolled (31%) were excluded: 14 with CPAP use \<3 hours, 5 with no evidence of OSA, and 9 with evidence of central or complex sleep apnea. A total of 62 eligible patients (69%) completed the run-in with evidence of OSA and chose to continue CPAP.

Participants by arm

ArmCount
CPAP Intervention
Participants will receive 3 nights of auto-CPAP in order to identify those with OSA using flow resistance detected by the device. After 3 nights, those without apparent OSA or with central apnea, and those who simply do not tolerate CPAP will be excluded from the study. An intensive CPAP adherence protocol (iCAP) will be initiated, including collaborative care with rehabilitation nurses, the study's sleep technologist and overnight respiratory therapists. After the run-in period, the sleep technologist will meet at least twice weekly with CPAP-tolerant participants during their rehabilitation stay for further OSA education and encouragement with a target adherence of 4 hours per night. Participants diagnosed with OSA by the device and tolerant will continue CPAP therapy during rehabilitation and at home for a treatment period of 3 months. Adherence will be downloaded remotely from participant's machines to encourage adherence to treatment and troubleshoot problems with the device.
90
Total90

Baseline characteristics

CharacteristicCPAP Intervention
Age, Continuous60.7 60.7 (SD 11.4) years
STANDARD_DEVIATION 11.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
7 Participants
Race (NIH/OMB)
Black or African American
15 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
8 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
55 Participants
Region of Enrollment
United States
90 Participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
63 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 90
other
Total, other adverse events
0 / 90
serious
Total, serious adverse events
0 / 90

Outcome results

Primary

3-month CPAP Adherence

Number of participants who continue CPAP after the run-in period who have acceptable adherence at 3 months, defined as using CPAP for an average of at least 4 hours a night on at least 70% of nights.

Time frame: 3 months

Population: Among the 62 of the enrolled 90 patients (69%) with evidence of OSA, 52 (84%) patients chose to continue CPAP on inpatient rehabilitation discharge. Three-month CPAP adherence was evaluated in these 52 participants.

ArmMeasureValue (NUMBER)
CPAP Intervention3-month CPAP Adherence32 participants adherent to CPAP at 90 days
Secondary

Change in NIH Stroke Scale

The National Institutes of Health Stroke scale (NIHSS) is a 15-item scale used to rank the severity of ischemic stroke. The NIHSS includes measurements for levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. The scores range from 0 to 42 with higher scores indicating greater neurologic impairment.

Time frame: NIHSS scores were obtained in-person on enrollment and at 90 ± 7 days from enrollment.

ArmMeasureValue (MEAN)Dispersion
CPAP InterventionChange in NIH Stroke Scale-3.8 score on a scaleStandard Deviation 2.6
Non-adherent ParticipantsChange in NIH Stroke Scale-1.6 score on a scaleStandard Deviation 2.2
Secondary

Change in the Cognitive Functional Independence Measure (FIM) Subscore

Change in the cognitive subscale of the Functional Independence Measure (FIM) over 3 months. The FIM, a disability scale measuring the burden of care associated with aspects of motor and cognitive function, includes a motor and cognitive component. The cognitive subscale includes 5 cognitive items: comprehension, expression, social interaction, problem solving and memory. Each of the 5 cognitive items are scored from 1 (complete dependence) to 7 (complete independence). The total scores from these 5 items for the cognitive subscale range from 5 to 35 with lower scores indicating greater functional disability. The 5 items from the cognitive subscale are combined with 13 items from the motor subscale yielding the 18 items of the total FIM with a minimum score of 18 and a maximum score of 126 with lower scores indicating greater functional disability.

Time frame: Between admission to rehabilitation unit and between 3-4 months following enrollment

ArmMeasureValue (MEAN)Dispersion
CPAP InterventionChange in the Cognitive Functional Independence Measure (FIM) Subscore8.2 score on a scaleStandard Deviation 6.5
Non-adherent ParticipantsChange in the Cognitive Functional Independence Measure (FIM) Subscore4.6 score on a scaleStandard Deviation 3
Secondary

Change in the Motor Functional Independence Measure (FIM) Subscore

Change in the motor subscale of the Functional Independence Measure (FIM) over 3 months. The FIM, a disability scale measuring the burden of care associated with aspects of motor and cognitive function, includes a motor and cognitive component. The motor subscale includes 13 motor items: eating, grooming, bathing, upper body dressing, lower body dressing, toileting, bladder management, bowel management, bed/chair transfer, toilet transfer, tub/shower transfer, walk/wheelchair locomotion and stair locomotion. Each of the 13 motor items are scored from 1 (complete dependence) to 7 (complete independence). The total scores from these 13 items for the motor subscale range from 13 to 91 with lower scores indicating greater functional disability. The 13 items from the motor subscale are combined with 5 items from the cognitive subscale yielding the 18 items of the total FIM with a minimum total score of 18 and a maximum score of 126 with lower scores indicating greater functional

Time frame: Between admission to rehabilitation unit and between 3-4 months following enrollment

ArmMeasureValue (MEAN)Dispersion
CPAP InterventionChange in the Motor Functional Independence Measure (FIM) Subscore31.2 score on a scaleStandard Deviation 15.7
Non-adherent ParticipantsChange in the Motor Functional Independence Measure (FIM) Subscore30.2 score on a scaleStandard Deviation 13.2
Secondary

CPAP Tolerance

Number of eligible participants (those who continue CPAP after the run-in period) who are willing to continue CPAP treatment upon discharge from the rehabilitation unit.

Time frame: Upon discharge from rehabilitation unit, typically at 14-21 days from CPAP initiation

Population: Participants with evidence of OSA during the 3-night run-in

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
CPAP InterventionCPAP Tolerance52 Participants

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026